FDA Recalls IBS drug Zelnorm
March 30, 2007After new studies, the FDA has issuing this public health advisory to for Zelnorm, (tegaserod maleate) after new astudies show it increase the risk of serious heart problems and stroke.
Novartis Pharmaceuticals Corporation, has agreed to take Zelnorm off the market because new safety analysis has found a higher chance of heart attack, stroke, and [...]
· 








